|8-K/AFeb 26, 9:08 PM ET

FrontView REIT, Inc. 8-K/A

Research Summary

AI-generated summary

Updated

FrontView REIT Issues $25M Series A Convertible Preferred Stock

What Happened

  • FrontView REIT, Inc. announced that on February 10, 2026 it issued 250,000 shares of Series A Convertible Preferred Stock at $100.00 per share, generating gross proceeds of approximately $25.0 million. The purchasers were Maewyn FVR II LP, Rebound Investment, LP and Petrus Special Situations Fund, L.P.
  • The filing is an amendment to a prior 8-K to include Item 1.01 (entry into a material definitive agreement), Items 3.02/3.03 (unregistered sales and material modification to holder rights), and Item 5.03 (amendments to articles/bylaws) that were inadvertently omitted from the original filing. The terms of the Series A Preferred were previously disclosed in the company’s Form 8-K filed November 18, 2025 and are incorporated by reference.

Key Details

  • Issuance date: February 10, 2026.
  • Shares issued: 250,000 shares of Series A Convertible Preferred Stock at $100.00 per share.
  • Gross proceeds: ~ $25.0 million.
  • Purchasers named: Maewyn FVR II LP, Rebound Investment, LP, Petrus Special Situations Fund, L.P.
  • Exhibits added: Articles Supplementary and a First Amendment (Feb 10, 2026) to the Amended & Restated Partnership Agreement of FrontView Operating Partnership LP; original disclosure otherwise unchanged.

Why It Matters

  • The company raised approximately $25.0M via a convertible preferred financing, which affects FrontView’s capital structure and provides additional capital for corporate needs. Because the securities are convertible preferred, they may convert into common equity under the previously disclosed terms—potentially affecting common shareholders in the future.
  • Retail investors should review the November 18, 2025 Form 8-K (for full terms of the Series A Preferred) and the exhibits in this amended filing to understand conversion mechanics, rights, and any changes to governance tied to the issuance.